Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nimodipime nanometer suspension freeze-dried composition, its preparing method and use

A nimodipine nano-suspension technology, which is applied in the direction of freeze-drying delivery, drug combination, cardiovascular system diseases, etc., can solve the problems of toxic and side effects, difficulty in accurate dosage, and less dissolution, so as to facilitate transportation and storage, Avoid irritation and reduce toxic and side effects

Inactive Publication Date: 2007-10-03
SHANGHAI INST OF PHARMA IND
View PDF0 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because nimodipine has very little solubility in water (about 1.4ug / ml at 37 degrees), its solid preparations are less dissolved in the gastrointestinal tract, and there is a strong hepatic first-pass effect in addition, resulting in bioavailability after oral administration. Low degree, requiring multiple doses
[0004] Yet, contain the organic solvent of about 30% in the nimodipine injection of clinical use, cause the stimulation of administration and toxic side effect (such as pain, vasculitis etc.)
At the same time, in clinical application, dilution is often required, and the concentration of organic solvents is reduced, resulting in the precipitation of nimodipine and interruption of treatment.
In order to avoid the precipitation of nimodipine in the infusion process, German bayer company uses accessories such as three-way valves to administer drugs through infusion pumps, which undoubtedly increases the cost of use and operational difficulty; Regularity often requires medical staff to pay special attention. Once the drug is precipitated, the drug must be replaced, which makes the dosage difficult to be accurate; and studies have shown that the drug content of nimodipine preparations solubilized by organic solvents is significantly reduced during storage and drug particles will be precipitated.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nimodipime nanometer suspension freeze-dried composition, its preparing method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Embodiment 1: Direct dispersion method and high-pressure homogeneous method are combined to prepare nimodipine nano-suspension

[0021] Weigh 250 mg of sodium deoxycholate and 188 500 mg of poloxamer, add it into 50 ml of water, stir it magnetically to dissolve it completely, then add 500 mg of nimodipine pulverized by airflow, stir magnetically for 10 min; stir under high shear for 1 min; The suspension was subjected to high-pressure homogenization under the conditions of 150 bar for 2 cycles, 500 bar for 2 cycles, and 1500 bar for 15 cycles to finally obtain a milky white suspension with a measured particle size of 200 nm.

Embodiment 2

[0022] Embodiment 2: microprecipitation method and high-pressure homogenization method are combined to prepare nimodipine nanosuspension

[0023] Add 500mg of poloxamer 188 into 48ml of water, stir magnetically to dissolve it completely; put 1ml of propylene glycol in a water bath at 50°C, then add 250mg of soybean lecithin and 100mg of nimodipine, after completely dissolving, use a syringe to Add dropwise into 48ml of aqueous solution, stir magnetically for 20 minutes; carry out high-pressure homogenization on the initial suspension, the conditions are 150bar cycle 2 times, 700bar cycle 10 times, and finally obtain a milky white suspension with a measured particle size of 350nm.

Embodiment 3

[0024] Embodiment 3: Direct dispersion method and ultrasonic method are combined to prepare nimodipine nanosuspension

[0025] Pipette 25ml of 1% Tween 80 solution and add it to 25ml of water, then add 500mg of poloxamer 188, stir it with magnetic force to make it evenly mixed, then add 125mg of nimodipine, stir it with magnetic force for 10min; stir with high shear for 1min; The suspension is subjected to probe ultrasonication under the condition of 70Khz intensity for 15min. In order to prevent excessive heating, it can be stopped every 5min. Finally, a milky white suspension was obtained, and the measured particle size was 520nm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

A freeze-dried nano-suspension of nimodipine for intravenous injection with low stimulation and high curative effect and stability contains nimodipine, surfactant and scaffolding agent. Its preparing process and application are also disclosed.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a nimodipine nanosuspension freeze-dried composition, a preparation method and application thereof. Background technique [0002] Nimodipine (molecular formula is C 21 h 26 N 2 o 2 , with a molecular weight of 418.45) belongs to 1,4-dihydropyridine calcium channel antagonists, which can selectively act on cerebral blood vessels, dilate cerebral arteries, increase cerebral blood flow without increasing brain metabolism, and also have anti-platelet aggregation effects . Clinically, it is mainly used for the treatment of cerebral vasospasm, sudden deafness, high blood pressure and migraine after arachnoid hemorrhage. [0003] At present, there are many formulations of nimodipine on the market at home and abroad, mainly including oral agents (such as ordinary tablets, sustained-release tablets, capsules, soft capsules) and injections (small water injections and large i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4422A61K9/19A61P9/00
Inventor 陆伟根熊若兰
Owner SHANGHAI INST OF PHARMA IND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products